175 related articles for article (PubMed ID: 36375474)
1. Efficacy of zinc carnosine in the treatment of colorectal cancer and its potential in combination with immunotherapy
Tang W; Liu H; Li X; Ooi TC; Rajab NF; Cao H; Sharif R
Aging (Albany NY); 2022 Nov; 14(21):8688-8699. PubMed ID: 36375474
[TBL] [Abstract][Full Text] [Related]
2. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
Chen YL; Wang GX; Lin BA; Huang JS
Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
[TBL] [Abstract][Full Text] [Related]
4. HNRNPL affects the proliferation and apoptosis of colorectal cancer cells by regulating PD-L1.
Zhao Y; Wang Y; Wang Q
Pathol Res Pract; 2021 Feb; 218():153320. PubMed ID: 33418347
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
6. Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade.
Song M; Qian C; Zhang T; Tang Y; Zhou Y; Wei Z; Wang A; Zhong C; Zhao Y; Lu Y
J Ethnopharmacol; 2023 Nov; 316():116735. PubMed ID: 37286115
[TBL] [Abstract][Full Text] [Related]
7. Zinc carnosine: Frontiers advances of supplement for cancer therapy.
Tang W; Liu H; Ooi TC; Rajab NF; Cao H; Sharif R
Biomed Pharmacother; 2022 Jul; 151():113157. PubMed ID: 35605299
[TBL] [Abstract][Full Text] [Related]
8. Zinc L-carnosine suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 murine macrophages cell line via activation of Nrf2/HO-1 signaling pathway.
Ooi TC; Chan KM; Sharif R
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):259-267. PubMed ID: 28697633
[TBL] [Abstract][Full Text] [Related]
9. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes.
Mahmood A; FitzGerald AJ; Marchbank T; Ntatsaki E; Murray D; Ghosh S; Playford RJ
Gut; 2007 Feb; 56(2):168-75. PubMed ID: 16777920
[TBL] [Abstract][Full Text] [Related]
10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
11. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
[TBL] [Abstract][Full Text] [Related]
12. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
[TBL] [Abstract][Full Text] [Related]
13. Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma.
Kang J; Zheng Z; Li X; Huang T; Rong D; Liu X; Qin M; Wang Y; Kong X; Song J; Lv C; Pan X
Cancer Cell Int; 2022 Oct; 22(1):312. PubMed ID: 36224624
[TBL] [Abstract][Full Text] [Related]
14. Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis.
Yang K; Zhang J; Bao C
BMC Cancer; 2021 Aug; 21(1):933. PubMed ID: 34412616
[TBL] [Abstract][Full Text] [Related]
15. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.
Zhang X; Lao M; Xu J; Duan Y; Yang H; Li M; Ying H; He L; Sun K; Guo C; Chen W; Jiang H; Zhang X; Bai X; Liang T
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35260434
[TBL] [Abstract][Full Text] [Related]
16. Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.
Sun G; Liu H; Zhao J; Zhang J; Huang T; Sun G; Zhao S; Zhang Z; Cao H; Rong D; Kong X; Ji Q; Liu L; Wang X; Tang W; Xia Y
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600662
[TBL] [Abstract][Full Text] [Related]
17. MGP promotes CD8
Rong D; Sun G; Zheng Z; Liu L; Chen X; Wu F; Gu Y; Dai Y; Zhong W; Hao X; Zhang C; Pan X; Tang J; Tang W; Wang X
Int J Biol Sci; 2022; 18(6):2345-2361. PubMed ID: 35414780
[TBL] [Abstract][Full Text] [Related]
18. TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.
Yang M; Huang Q; Li C; Jiang Z; Sun J; Wang Z; Liang R; Li D; Li B; Zhao H
Front Immunol; 2021; 12():647540. PubMed ID: 33897695
[TBL] [Abstract][Full Text] [Related]
19. Targeting VCP potentiates immune checkpoint therapy for colorectal cancer.
Wang F; Qi Q; Qin B; Wang Y; Huang Y; Li Q; Shen X; Wang X; Yang S; Pan G; Chen J; Qin Z; Chen X; Yang Y; Zeng Y; Liu J; Li Y; Li Y; Cheng Z; Lin X; Xing F; Zhang Y; Wang G; Li K; Jiang Z; Zhang H
Cell Rep; 2023 Nov; 42(11):113318. PubMed ID: 37865914
[TBL] [Abstract][Full Text] [Related]
20. Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.
Kong X; Zheng Z; Song G; Zhang Z; Liu H; Kang J; Sun G; Sun G; Huang T; Li X; Rong D; Wang K; Tang W; Xia Y
Front Immunol; 2022; 13():876048. PubMed ID: 35812439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
